杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/06/15 | 1,257 | 1,260 | 1,240 | 1,251 | -17 | -1.3% | 210,000 |
| 2010/06/14 | 1,252 | 1,273 | 1,252 | 1,268 | +12 | +1% | 208,000 |
| 2010/06/11 | 1,251 | 1,258 | 1,246 | 1,256 | +10 | +0.8% | 184,000 |
| 2010/06/10 | 1,243 | 1,252 | 1,234 | 1,246 | +1 | +0.1% | 226,000 |
| 2010/06/09 | 1,241 | 1,249 | 1,229 | 1,245 | +4 | +0.3% | 292,000 |
| 2010/06/08 | 1,224 | 1,242 | 1,222 | 1,241 | +28 | +2.3% | 223,000 |
| 2010/06/07 | 1,219 | 1,230 | 1,209 | 1,213 | -30 | -2.4% | 256,000 |
| 2010/06/04 | 1,250 | 1,250 | 1,238 | 1,243 | +1 | +0.1% | 308,000 |
| 2010/06/03 | 1,230 | 1,247 | 1,230 | 1,242 | +16 | +1.3% | 367,000 |
| 2010/06/02 | 1,222 | 1,237 | 1,222 | 1,226 | -15 | -1.2% | 298,000 |
| 2010/06/01 | 1,249 | 1,252 | 1,239 | 1,241 | -4 | -0.3% | 215,000 |
| 2010/05/31 | 1,213 | 1,250 | 1,213 | 1,245 | +19 | +1.5% | 388,000 |
| 2010/05/28 | 1,245 | 1,245 | 1,217 | 1,226 | -19 | -1.5% | 686,000 |
| 2010/05/27 | 1,264 | 1,265 | 1,240 | 1,245 | -33 | -2.6% | 524,000 |
| 2010/05/26 | 1,282 | 1,297 | 1,277 | 1,278 | -18 | -1.4% | 287,000 |
| 2010/05/25 | 1,286 | 1,303 | 1,286 | 1,296 | -10 | -0.8% | 304,000 |
| 2010/05/24 | 1,282 | 1,314 | 1,280 | 1,306 | +20 | +1.6% | 374,000 |
| 2010/05/21 | 1,297 | 1,303 | 1,280 | 1,286 | -34 | -2.6% | 345,000 |
| 2010/05/20 | 1,319 | 1,326 | 1,305 | 1,320 | ±0 | ±0% | 264,000 |
| 2010/05/19 | 1,313 | 1,330 | 1,304 | 1,320 | +7 | +0.5% | 257,000 |
| 2010/05/18 | 1,317 | 1,331 | 1,308 | 1,313 | +3 | +0.2% | 283,000 |
| 2010/05/17 | 1,297 | 1,311 | 1,291 | 1,310 | ±0 | ±0% | 291,000 |
| 2010/05/14 | 1,316 | 1,316 | 1,300 | 1,310 | -8 | -0.6% | 205,000 |
| 2010/05/13 | 1,312 | 1,322 | 1,304 | 1,318 | +12 | +0.9% | 365,000 |
| 2010/05/12 | 1,308 | 1,317 | 1,295 | 1,306 | -20 | -1.5% | 480,000 |
| 2010/05/11 | 1,318 | 1,363 | 1,311 | 1,326 | +8 | +0.6% | 315,000 |
| 2010/05/10 | 1,291 | 1,321 | 1,285 | 1,318 | +2 | +0.2% | 197,000 |
| 2010/05/07 | 1,320 | 1,328 | 1,308 | 1,316 | -24 | -1.8% | 220,000 |
| 2010/05/06 | 1,322 | 1,356 | 1,322 | 1,340 | -11 | -0.8% | 302,000 |
| 2010/04/30 | 1,332 | 1,357 | 1,331 | 1,351 | +15 | +1.1% | 284,000 |
| 2010/04/28 | 1,335 | 1,344 | 1,331 | 1,336 | -15 | -1.1% | 228,000 |
| 2010/04/27 | 1,356 | 1,356 | 1,345 | 1,351 | -4 | -0.3% | 111,000 |
| 2010/04/26 | 1,354 | 1,362 | 1,349 | 1,355 | +2 | +0.1% | 179,000 |
| 2010/04/23 | 1,345 | 1,354 | 1,341 | 1,353 | +12 | +0.9% | 177,000 |
| 2010/04/22 | 1,333 | 1,341 | 1,324 | 1,341 | +8 | +0.6% | 213,000 |
| 2010/04/21 | 1,330 | 1,334 | 1,325 | 1,333 | +1 | +0.1% | 209,000 |
| 2010/04/20 | 1,333 | 1,337 | 1,330 | 1,332 | -1 | -0.1% | 118,000 |
| 2010/04/19 | 1,332 | 1,337 | 1,330 | 1,333 | -21 | -1.6% | 150,000 |
| 2010/04/16 | 1,356 | 1,357 | 1,350 | 1,354 | -2 | -0.1% | 90,000 |
| 2010/04/15 | 1,355 | 1,363 | 1,355 | 1,356 | -6 | -0.4% | 70,000 |
| 2010/04/14 | 1,350 | 1,363 | 1,350 | 1,362 | +7 | +0.5% | 125,000 |
| 2010/04/13 | 1,365 | 1,365 | 1,350 | 1,355 | -3 | -0.2% | 122,000 |
| 2010/04/12 | 1,370 | 1,370 | 1,356 | 1,358 | +7 | +0.5% | 187,000 |
| 2010/04/09 | 1,345 | 1,356 | 1,343 | 1,351 | -3 | -0.2% | 146,000 |
| 2010/04/08 | 1,349 | 1,358 | 1,349 | 1,354 | -9 | -0.7% | 94,000 |
| 2010/04/07 | 1,350 | 1,363 | 1,350 | 1,363 | +18 | +1.3% | 122,000 |
| 2010/04/06 | 1,332 | 1,348 | 1,332 | 1,345 | +4 | +0.3% | 174,000 |
| 2010/04/05 | 1,335 | 1,342 | 1,335 | 1,341 | +6 | +0.4% | 150,000 |
| 2010/04/02 | 1,355 | 1,355 | 1,327 | 1,335 | -9 | -0.7% | 181,000 |
| 2010/04/01 | 1,335 | 1,350 | 1,335 | 1,344 | - | - | 179,000 |
3401～
3450
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | - | +2.6% | +11.5% | - | - | - |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ジーエヌアイ | - | +52.1% | +23.3% | - | - | - |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
| 持田薬 | - | -1.2% | -37.3% | - | - | - |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 鳥居薬 | - | +7.3% | +16.8% | - | - | - |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| ゼリア新薬 | - | +6.8% | +18.7% | - | - | - |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
該当銘柄がありません
チャート関連のコラム
